CLINICAL_TRIALS
trial_result
· 2021-02-01
Clinical Trial Update: Tofacitinib for Inflammatory Eye Disease [Phase 2]
Summary
A Phase 2 trial evaluating tofacitinib for inflammatory eye diseases (uveitis and scleritis) with results posted in 2021; current status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Uveitis, Scleritis | Phase 2 | Status: UNKNOWN | Results posted: 2021-02-01